Prospective study evaluating the effect of impaired tamoxifen metabolisation on efficacy in breast cancer patients receiving tamoxifen in the neo-adjuvant or metastatic setting

Autor:	Henk-Jan Guchelaar, Chantal Blomme, Anneleen Lintermans, Robert Paridaens, J. Decloedt, Peter Vuylsteke, Patrick Berteloot, A Poppe, Diether Lambrechts, Lynn Jongen, Patrick Neven, Didier Verhoeven, Kathleen Van Asten, Markus Joerger, Anne-Sophie Dieudonné, Vincent O. Dezentjé, Ben Van Calster, Ignace Vergote, Hans Wildiers, W. Wynendaele
Rok vydání:	2016
Předmět:	Oncology Gynecology Cancer Research medicine.medical_specialty business.industry Estrogen receptor Neo adjuvant medicine.disease 030226 pharmacology & pharmacy 03 medical and health sciences 0302 clinical medicine Breast cancer 030220 oncology & carcinogenesis Internal medicine medicine skin and connective tissue diseases Prospective cohort study Adverse effect business hormones hormone substitutes and hormone antagonists Tamoxifen medicine.drug
Zdroj:	Journal of Clinical Oncology. 34:523-523
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2016.34.15_suppl.523
Popis:	523Background: Tamoxifen is commonly used to treat estrogen receptor (ER)-positive breast cancers, though the response to tamoxifen and its adverse event profile have a high degree of inter-individ...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::c50f2d5a0c56498d2c98641d2c0b0c8f https://doi.org/10.1200/jco.2016.34.15_suppl.523 Zobrazit plný text záznamu